<?xml version="1.0" encoding="UTF-8"?>
<collection>
<dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:invenio="http://invenio-software.org/elements/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:identifier>doi:10.1016/j.diagmicrobio.2016.02.021</dc:identifier><dc:language>eng</dc:language><dc:creator>González-Domínguez, Maria</dc:creator><dc:creator>Seral, Cristina</dc:creator><dc:creator>Potel, Carmen</dc:creator><dc:creator>Sáenz, Yolanda</dc:creator><dc:creator>Alvarez, Maximiliano</dc:creator><dc:creator>Torres, Carmen</dc:creator><dc:creator>Castillo, Francisco Javier</dc:creator><dc:title>Genotypic and phenotypic characterization of methicillin-resistant Staphylococcus aureus (MRSA) clones with high-level mupirocin resistance</dc:title><dc:identifier>ART-2016-94412</dc:identifier><dc:description>An elevated proportion (27.2%) of high-level mupirocin-resistant methicillin-resistant Staphylococcus aureus (HLMUPR-MRSA) isolates were found in our environment in one year period. HLMUPR-MRSA isolates were mainly collected from skin and soft tissue samples, and diabetes was the main related comorbidity condition. These isolates were more frequently found in vascular surgery. HLMUPR-MRSA were more resistant to aminoglycosides than mupirocin-susceptible MRSA, linked to the presence of bifunctional and/or nucleotidyltransferase enzymes with/without macrolide resistance associated with the msr(A) gene. Most of HLMUPR-MRSA isolates belonged to ST125/t067. Nine IS257-ileS2 amplification patterns (p3 was the most frequent) were observed in HLMUPR-MRSA isolates, suggesting the presence of several mupirocin-resistance-carrying plasmids in our environment and promoting the emergence of mupirocin resistance. The presence of the same IS257-ileS2 amplification pattern p3 in 65% of HLMUPR-MRSA, all of them ST125/t067, suggests a clonal spread in our hospital and community environment which could explain the high prevalence of HLMUPR-MRSA during the study period. An outbreak situation or an increase in mupirocin consumption was not observed.</dc:description><dc:date>2016</dc:date><dc:source>http://zaguan.unizar.es/record/60606</dc:source><dc:doi>10.1016/j.diagmicrobio.2016.02.021</dc:doi><dc:identifier>http://zaguan.unizar.es/record/60606</dc:identifier><dc:identifier>oai:zaguan.unizar.es:60606</dc:identifier><dc:relation>info:eu-repo/grantAgreement/ES/DGA/B24-211130</dc:relation><dc:identifier.citation>Diagnostic Microbiology and Infectious Disease 85 (2016), 213-217</dc:identifier.citation><dc:rights>by-nc-nd</dc:rights><dc:rights>http://creativecommons.org/licenses/by-nc-nd/3.0/es/</dc:rights><dc:rights>info:eu-repo/semantics/openAccess</dc:rights></dc:dc>

</collection>